Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Payables: 2019-2025

Historic Payables for Burning Rock Biotech (BNR) over the last 1 years, with Jun 2025 value amounting to $592,000.

  • Burning Rock Biotech's Payables was N/A to $592,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $15.2 million, marking a year-over-year change of. This contributed to the annual value of $4.7 million for FY2024, which is 84.96% up from last year.
  • As of Q2 2025, Burning Rock Biotech's Payables stood at $592,000, which was down 87.42% from $4.7 million recorded in Q4 2024.
  • Burning Rock Biotech's Payables' 5-year high stood at $10.3 million during Q4 2021, with a 5-year trough of $157,000 in Q2 2022.
  • Its 3-year average for Payables is $2.6 million, with a median of $2.5 million in 2023.
  • Per our database at Business Quant, Burning Rock Biotech's Payables slumped by 65.56% in 2023 and then soared by 84.96% in 2024.
  • Over the past 5 years, Burning Rock Biotech's Payables (Quarterly) stood at $10.3 million in 2021, then decreased by 28.08% to $7.4 million in 2022, then tumbled by 65.56% to $2.5 million in 2023, then surged by 84.96% to $4.7 million in 2024, then reached $592,000 in 2025.
  • Its Payables was $592,000 in Q2 2025, compared to $4.7 million in Q4 2024 and $2.5 million in Q4 2023.